Works by Schalkwijk, Stein


Results: 23
    1
    2
    3
    4
    5
    6
    7

    Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.

    Published in:
    Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00239
    By:
    • Mulligan, Nikki;
    • Schalkwijk, Stein;
    • Best, Brookie M.;
    • Colbers, Angela;
    • Wang, Jiajia;
    • Capparelli, Edmund V.;
    • Moltó, José;
    • Stek, Alice M.;
    • Taylor, Graham;
    • Smith, Elizabeth;
    • Tenorio, Carmen Hidalgo;
    • Chakhtoura, Nahida;
    • van Kasteren, Marjo;
    • Fletcher, Courtney V.;
    • Mirochnick, Mark;
    • Burger, David
    Publication type:
    Article
    8
    9
    10

    Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

    Published in:
    Clinical Infectious Diseases, 2015, v. 61, n. 10, p. 1582, doi. 10.1093/cid/civ587
    By:
    • Colbers, Angela;
    • Best, Brookie;
    • Schalkwijk, Stein;
    • Jiajia Wang;
    • Stek, Alice;
    • Tenorio, Carmen Hidalgo;
    • Hawkins, David;
    • Taylor, Graham;
    • Kreitchmann, Regis;
    • Burchett, Sandra;
    • Haberl, Annette;
    • Kabeya, Kabamba;
    • van Kasteren, Marjo;
    • Smith, Elizabeth;
    • Capparelli, Edmund;
    • Burger, David;
    • Mirochnick, Mark
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours.

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 10, p. 1906, doi. 10.1038/s41416-023-02185-2
    By:
    • Johnson, Melissa L.;
    • Wang, Judy S.;
    • Falchook, Gerald;
    • Greenlees, Carol;
    • Jones, Suzanne;
    • Strickland, Donald;
    • Fabbri, Giulia;
    • Kennedy, Caroline;
    • Elizabeth Pease, J.;
    • Sainsbury, Liz;
    • MacDonald, Alexander;
    • Schalkwijk, Stein;
    • Szekeres, Philip;
    • Cosaert, Jan;
    • Burris III, Howard
    Publication type:
    Article
    20
    21
    22
    23

    A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 11, p. 2625, doi. 10.1080/10428194.2021.1938027
    By:
    • Collins, Graham P.;
    • Clevenger, Tracy N.;
    • Burke, Kathleen A.;
    • Yang, Buyue;
    • MacDonald, Alex;
    • Cunningham, David;
    • Fox, Christopher P.;
    • Goy, Andre;
    • Gribben, John;
    • Nowakowski, Grzegorz S.;
    • Roschewski, Mark;
    • Vose, Julie M.;
    • Vallurupalli, Anusha;
    • Cheung, Jean;
    • Raymond, Amelia;
    • Nuttall, Barrett;
    • Stetson, Dan;
    • Dougherty, Brian A.;
    • Schalkwijk, Stein;
    • Carnevalli, Larissa S.
    Publication type:
    Article